Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Topical vitamin D3 does not prevent hair loss from chemotherapy.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Moorvadi choornam may help reduce chemotherapy side effects.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

A woman experienced temporary hair loss after taking albendazole, which resolved on its own within 3 months.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

The botanical treatment for hair loss shows promise, especially for children.

Raltegravir may cause hair loss in some patients.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Some tuberculosis drugs may cause hair loss, but hair might regrow after treatment or changing the drugs.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.